Do analysts prefer CGC or ACB?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Canopy Growth 1 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.17 Aurora Cannabis 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts rate CGC or CRON?

Cronos Group has a consensus price target of $2.30, indicating a potential downside of 15.13%. Given Cronos Group's stronger consensus rating and higher possible upside, analysts clearly believe Cronos Group is more favorable than Canopy Growth. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Canopy Growth 1 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.17 Cronos Group 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20

Does the media prefer CGC or CRON?

In the previous week, Canopy Growth had 7 more articles in the media than Cronos Group. MarketBeat recorded 11 mentions for Canopy Growth and 4 mentions for Cronos Group. Cronos Group's average media sentiment score of 0.66 beat Canopy Growth's score of 0.27 indicating that Cronos Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Canopy Growth 5 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral Cronos Group 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate CGC or OGI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Canopy Growth 1 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.17 Organigram Global 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33

Do analysts recommend SNDL or CGC?

SNDL currently has a consensus price target of $5.00, suggesting a potential upside of 252.11%. Given SNDL's higher possible upside, equities research analysts plainly believe SNDL is more favorable than Canopy Growth. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score SNDL 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Canopy Growth 1 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.17

Which has stronger earnings and valuation, SNDL or CGC?

SNDL has higher revenue and earnings than Canopy Growth. SNDL is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio SNDL $677.32M 0.54 -$11.29M -$0.03 N/A Canopy Growth $251.01M 1.56 -$429.86M -$0.59 N/A

Is SNDL or CGC more profitable?

SNDL has a net margin of -1.19% compared to Canopy Growth's net margin of -75.27%. SNDL's return on equity of -1.02% beat Canopy Growth's return on equity. Company Net Margins Return on Equity Return on Assets SNDL -1.19% -1.02% -0.85% Canopy Growth -75.27% -26.95% -17.20%

Do analysts recommend TLRY or CGC?

Tilray Brands currently has a consensus target price of $11.50, suggesting a potential upside of 143.13%. Given Tilray Brands' stronger consensus rating and higher possible upside, analysts plainly believe Tilray Brands is more favorable than Canopy Growth. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tilray Brands 1 Sell rating(s) 4 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.25 Canopy Growth 1 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.17

Does the media favor TLRY or CGC?

In the previous week, Tilray Brands had 25 more articles in the media than Canopy Growth. MarketBeat recorded 36 mentions for Tilray Brands and 11 mentions for Canopy Growth. Tilray Brands' average media sentiment score of 0.55 beat Canopy Growth's score of 0.27 indicating that Tilray Brands is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tilray Brands 13 Very Positive mention(s) 7 Positive mention(s) 15 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Canopy Growth 5 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral

Canopy Growth (CGC) Competitors

$0.97 0.00 (0.00%)

Closing price 06/18/2026 04:00 PM Eastern

Extended Trading

$0.97 0.00 (-0.02%)

As of 06/18/2026 07:52 PM Eastern

Compare

CGC vs. ACB, CRON, OGI, SNDL, and TLRY

Should you buy Canopy Growth stock or one of its competitors? MarketBeat compares Canopy Growth with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Canopy Growth include Aurora Cannabis (ACB), Cronos Group (CRON), Organigram Global (OGI), SNDL (SNDL), and Tilray Brands (TLRY). These companies are all part of the "pharmaceutical products" industry.

How does Canopy Growth compare to Aurora Cannabis?

Canopy Growth (NASDAQ:CGC) and Aurora Cannabis (NASDAQ:ACB) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, media sentiment, dividends, profitability, institutional ownership, analyst recommendations, risk and valuation.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Canopy Growth	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17
Aurora Cannabis	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Aurora Cannabis has lower revenue, but higher earnings than Canopy Growth. Aurora Cannabis is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Canopy Growth	$251.01M	1.56	-$429.86M	-$0.59	N/A
Aurora Cannabis	$247.82M	0.73	-$88.13M	-$1.56	N/A

Aurora Cannabis has a net margin of -33.57% compared to Canopy Growth's net margin of -75.27%. Aurora Cannabis' return on equity of 0.10% beat Canopy Growth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Canopy Growth	-75.27%	-26.95%	-17.20%
Aurora Cannabis	-33.57%	0.10%	0.07%

Canopy Growth has a beta of 0.77, meaning that its stock price is 23% less volatile than the broader market. Comparatively, Aurora Cannabis has a beta of 0.53, meaning that its stock price is 47% less volatile than the broader market.

3.3% of Canopy Growth shares are held by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are held by institutional investors. 0.2% of Canopy Growth shares are held by company insiders. Comparatively, 0.0% of Aurora Cannabis shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Canopy Growth had 11 more articles in the media than Aurora Cannabis. MarketBeat recorded 11 mentions for Canopy Growth and 0 mentions for Aurora Cannabis. Canopy Growth's average media sentiment score of 0.27 beat Aurora Cannabis' score of -0.70 indicating that Canopy Growth is being referred to more favorably in the media.

Company	Overall Sentiment
Canopy Growth	Neutral
Aurora Cannabis	Negative

Summary

Canopy Growth beats Aurora Cannabis on 10 of the 15 factors compared between the two stocks.

How does Canopy Growth compare to Cronos Group?

Canopy Growth (NASDAQ:CGC) and Cronos Group (NASDAQ:CRON) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, institutional ownership, earnings, analyst recommendations, profitability and valuation.

Cronos Group has a net margin of -1.14% compared to Canopy Growth's net margin of -75.27%. Cronos Group's return on equity of -1.26% beat Canopy Growth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Canopy Growth	-75.27%	-26.95%	-17.20%
Cronos Group	-1.14%	-1.26%	-1.20%

Cronos Group has a consensus price target of $2.30, indicating a potential downside of 15.13%. Given Cronos Group's stronger consensus rating and higher possible upside, analysts clearly believe Cronos Group is more favorable than Canopy Growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Canopy Growth	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17
Cronos Group	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20

In the previous week, Canopy Growth had 7 more articles in the media than Cronos Group. MarketBeat recorded 11 mentions for Canopy Growth and 4 mentions for Cronos Group. Cronos Group's average media sentiment score of 0.66 beat Canopy Growth's score of 0.27 indicating that Cronos Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Canopy Growth	5 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral
Cronos Group	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

3.3% of Canopy Growth shares are owned by institutional investors. Comparatively, 8.7% of Cronos Group shares are owned by institutional investors. 0.2% of Canopy Growth shares are owned by insiders. Comparatively, 7.8% of Cronos Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Canopy Growth has a beta of 0.77, indicating that its stock price is 23% less volatile than the broader market. Comparatively, Cronos Group has a beta of 0.89, indicating that its stock price is 11% less volatile than the broader market.

Cronos Group has lower revenue, but higher earnings than Canopy Growth. Canopy Growth is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Canopy Growth	$251.01M	1.56	-$429.86M	-$0.59	N/A
Cronos Group	$146.59M	6.90	-$9.45M	$0.01	271.00

Summary

Cronos Group beats Canopy Growth on 13 of the 15 factors compared between the two stocks.

How does Canopy Growth compare to Organigram Global?

Canopy Growth (NASDAQ:CGC) and Organigram Global (NASDAQ:OGI) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, institutional ownership, earnings, analyst recommendations, profitability and valuation.

Organigram Global has a net margin of -9.22% compared to Canopy Growth's net margin of -75.27%. Organigram Global's return on equity of -13.41% beat Canopy Growth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Canopy Growth	-75.27%	-26.95%	-17.20%
Organigram Global	-9.22%	-13.41%	-9.09%

Organigram Global has lower revenue, but higher earnings than Canopy Growth. Organigram Global is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Canopy Growth	$251.01M	1.56	-$429.86M	-$0.59	N/A
Organigram Global	$185.07M	0.73	-$17.70M	-$0.13	N/A

3.3% of Canopy Growth shares are owned by institutional investors. Comparatively, 34.6% of Organigram Global shares are owned by institutional investors. 0.2% of Canopy Growth shares are owned by insiders. Comparatively, 0.1% of Organigram Global shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Canopy Growth had 11 more articles in the media than Organigram Global. MarketBeat recorded 11 mentions for Canopy Growth and 0 mentions for Organigram Global. Canopy Growth's average media sentiment score of 0.27 beat Organigram Global's score of 0.00 indicating that Canopy Growth is being referred to more favorably in the media.

Company	Overall Sentiment
Canopy Growth	Neutral
Organigram Global	Neutral

Canopy Growth has a beta of 0.77, indicating that its stock price is 23% less volatile than the broader market. Comparatively, Organigram Global has a beta of 1.43, indicating that its stock price is 43% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Canopy Growth	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17
Organigram Global	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Summary

Organigram Global beats Canopy Growth on 8 of the 14 factors compared between the two stocks.

How does Canopy Growth compare to SNDL?

SNDL (NASDAQ:SNDL) and Canopy Growth (NASDAQ:CGC) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability.

SNDL has a net margin of -1.19% compared to Canopy Growth's net margin of -75.27%. SNDL's return on equity of -1.02% beat Canopy Growth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SNDL	-1.19%	-1.02%	-0.85%
Canopy Growth	-75.27%	-26.95%	-17.20%

3.3% of Canopy Growth shares are owned by institutional investors. 0.2% of Canopy Growth shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

SNDL has a beta of 0.91, suggesting that its stock price is 9% less volatile than the broader market. Comparatively, Canopy Growth has a beta of 0.77, suggesting that its stock price is 23% less volatile than the broader market.

SNDL currently has a consensus price target of $5.00, suggesting a potential upside of 252.11%. Given SNDL's higher possible upside, equities research analysts plainly believe SNDL is more favorable than Canopy Growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SNDL	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Canopy Growth	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17

SNDL has higher revenue and earnings than Canopy Growth. SNDL is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SNDL	$677.32M	0.54	-$11.29M	-$0.03	N/A
Canopy Growth	$251.01M	1.56	-$429.86M	-$0.59	N/A

In the previous week, Canopy Growth had 11 more articles in the media than SNDL. MarketBeat recorded 11 mentions for Canopy Growth and 0 mentions for SNDL. Canopy Growth's average media sentiment score of 0.27 beat SNDL's score of -0.55 indicating that Canopy Growth is being referred to more favorably in the news media.

Company	Overall Sentiment
SNDL	Negative
Canopy Growth	Neutral

Summary

SNDL and Canopy Growth tied by winning 8 of the 16 factors compared between the two stocks.

How does Canopy Growth compare to Tilray Brands?

Tilray Brands (NASDAQ:TLRY) and Canopy Growth (NASDAQ:CGC) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, media sentiment, dividends, analyst recommendations, profitability and earnings.

In the previous week, Tilray Brands had 25 more articles in the media than Canopy Growth. MarketBeat recorded 36 mentions for Tilray Brands and 11 mentions for Canopy Growth. Tilray Brands' average media sentiment score of 0.55 beat Canopy Growth's score of 0.27 indicating that Tilray Brands is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tilray Brands	13 Very Positive mention(s)	7 Positive mention(s)	15 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
Canopy Growth	5 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral

Canopy Growth has lower revenue, but higher earnings than Tilray Brands. Canopy Growth is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tilray Brands	$821.31M	0.67	-$2.19B	-$13.65	N/A
Canopy Growth	$251.01M	1.56	-$429.86M	-$0.59	N/A

Tilray Brands currently has a consensus target price of $11.50, suggesting a potential upside of 143.13%. Given Tilray Brands' stronger consensus rating and higher possible upside, analysts plainly believe Tilray Brands is more favorable than Canopy Growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tilray Brands	1 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.25
Canopy Growth	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17

Canopy Growth has a net margin of -75.27% compared to Tilray Brands' net margin of -156.51%. Tilray Brands' return on equity of -3.31% beat Canopy Growth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tilray Brands	-156.51%	-3.31%	-2.42%
Canopy Growth	-75.27%	-26.95%	-17.20%

9.4% of Tilray Brands shares are held by institutional investors. Comparatively, 3.3% of Canopy Growth shares are held by institutional investors. 0.8% of Tilray Brands shares are held by company insiders. Comparatively, 0.2% of Canopy Growth shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Tilray Brands has a beta of 1.88, meaning that its stock price is 88% more volatile than the broader market. Comparatively, Canopy Growth has a beta of 0.77, meaning that its stock price is 23% less volatile than the broader market.

Summary

Tilray Brands beats Canopy Growth on 12 of the 16 factors compared between the two stocks.

Get Canopy Growth News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CGC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CGC vs. The Competition

Export

Metric	Canopy Growth	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$390.87M	$8.34B	$6.43B	$12.60B
Dividend Yield	N/A	2.55%	2.68%	5.81%
P/E Ratio	-1.64	15.57	24.75	24.42
Price / Sales	1.56	7.37	530.01	109.07
Price / Cash	N/A	17.05	45.07	55.09
Price / Book	0.51	3.28	10.80	6.58
Net Income	-$429.86M	$224.06M	$3.57B	$337.17M
7 Day Performance	-3.28%	-1.92%	0.73%	0.83%
1 Month Performance	-6.10%	-0.44%	1.35%	3.27%
1 Year Performance	-22.00%	0.83%	29.31%	36.05%

Canopy Growth Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CGC Canopy Growth	1.4842 of 5 stars	$0.97 flat	N/A	-25.0%	$390.87M	$251.01M	N/A	3,150	Earnings Report
ACB Aurora Cannabis	0.4692 of 5 stars	$3.41 +0.9%	N/A	-37.4%	$207.34M	$246.72M	N/A	1,130	Analyst Upgrade
CRON Cronos Group	1.6186 of 5 stars	$2.77 +1.1%	$2.30 -17.0%	+41.9%	$1.02B	$146.59M	277.28	450
OGI Organigram Global	0.5183 of 5 stars	$1.07 +0.9%	N/A	-26.9%	$149.21M	$185.07M	N/A	1,139
SNDL SNDL	3.706 of 5 stars	$1.45 +2.1%	$5.00 +244.8%	+11.8%	$365.50M	$677.32M	N/A	2,751

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CGC) was last updated on 6/20/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Canopy Growth (CGC) Competitors

CGC vs. ACB, CRON, OGI, SNDL, and TLRY

How does Canopy Growth compare to Aurora Cannabis?

Summary

How does Canopy Growth compare to Cronos Group?

Summary

How does Canopy Growth compare to Organigram Global?

Summary

How does Canopy Growth compare to SNDL?

Summary

How does Canopy Growth compare to Tilray Brands?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CGC vs. The Competition

Canopy Growth Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Canopy Growth (CGC) Competitors

CGC vs. ACB, CRON, OGI, SNDL, and TLRY

How does Canopy Growth compare to Aurora Cannabis?

Do analysts prefer CGC or ACB?

Which has stronger earnings & valuation, CGC or ACB?

Is CGC or ACB more profitable?

Which has more volatility & risk, CGC or ACB?

Do institutionals and insiders have more ownership in CGC or ACB?

Does the media favor CGC or ACB?

Summary

How does Canopy Growth compare to Cronos Group?

Is CGC or CRON more profitable?

Do analysts rate CGC or CRON?

Does the media prefer CGC or CRON?

Do institutionals & insiders believe in CGC or CRON?

Which has more risk & volatility, CGC or CRON?

Which has stronger valuation and earnings, CGC or CRON?

Summary

How does Canopy Growth compare to Organigram Global?

Is CGC or OGI more profitable?

Which has stronger valuation and earnings, CGC or OGI?

Do institutionals & insiders believe in CGC or OGI?

Does the media prefer CGC or OGI?

Which has more risk & volatility, CGC or OGI?

Do analysts rate CGC or OGI?

Summary

How does Canopy Growth compare to SNDL?

Is SNDL or CGC more profitable?

Do institutionals and insiders have more ownership in SNDL or CGC?

Which has more volatility and risk, SNDL or CGC?

Do analysts recommend SNDL or CGC?

Which has stronger earnings and valuation, SNDL or CGC?

Does the media refer more to SNDL or CGC?

Summary

How does Canopy Growth compare to Tilray Brands?

Does the media favor TLRY or CGC?

Which has better earnings and valuation, TLRY or CGC?

Do analysts recommend TLRY or CGC?

Is TLRY or CGC more profitable?

Do insiders & institutionals believe in TLRY or CGC?

Which has more risk & volatility, TLRY or CGC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CGC vs. The Competition

Canopy Growth Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools